dc.contributor.author
Catalina-Hernández, Èric
dc.contributor.author
López-Martín, Mario
dc.contributor.author
Aguilella-Arzo, Marcel
dc.contributor.author
Peralvarez-Marin, Alex
dc.date.accessioned
2025-08-31T18:30:03Z
dc.date.available
2025-08-31T18:30:03Z
dc.identifier
https://ddd.uab.cat/record/313553
dc.identifier
urn:10.1016/j.ijbiomac.2025.144567
dc.identifier
urn:oai:ddd.uab.cat:313553
dc.identifier
urn:scopus_id:105006763229
dc.identifier
urn:articleid:18790003v316p144567
dc.identifier
urn:pmid:40412686
dc.identifier
urn:oai:egreta.uab.cat:publications/34e1df51-dcf8-4b2f-ad03-8ce0572ea8b0
dc.identifier.uri
https://hdl.handle.net/2072/486204
dc.description.abstract
Altres ajuts: acords transformatius de la UAB
dc.description.abstract
Dynorphins are natural neuropeptides that act like opioids but can also cause harmful effects like neurological issues and cell death. Dynorphin A (DynA WT) and its variants (L5S, R6W, and R9C) may disrupt lipid bilayers, leading to pathophysiological effects. Using steered and conventional molecular dynamics simulations, we evaluated how DynA and its variants interact with and penetrate model lipid bilayers. We defined three lipid compositions: neutral, cholesterol-rich and negatively charged, representing different sections of a cell membrane to characterize specific lipid-protein interactions. The R6W peptide cannot find a stable state in any membrane, always returning to the water-bilayer interface. DynA L5S uniquely disturbs neutral lipid bilayers by forming proteolipid pores at the hydrophobic core. DynA WT and L5S are capable to form more stable proteolipid pores in neutral bilayers with cholesterol. L5S and R9C disrupt negatively charged bilayers with cholesterol, again, being able to form stable toroidal pores. The computational strategy presented here allows to study how single amino acid changes in DynA peptides affect their ability to disturb different bilayer compositions.
dc.format
application/pdf
dc.relation
International journal of biological macromolecules ; Vol. 316 (june 2025), p. 144567
dc.rights
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
dc.rights
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Membrane transport
dc.subject
Peptide-bilayer interactions
dc.subject
Membrane disturbing potential
dc.subject
Molecular dynamics simulations
dc.title
Membrane disruption potential of endogenous opioid neuropeptide Dynorphin A and related clinical variants